VCAST is supported by AI engine that helps Medicalgorithmics analyze coronary CT data and provide functional information that supports clinical decisions.
Public source
Publisher name
Public post
AI has become one of the biggest topics in healthcare. But interestingly, that's rarely where conversations with clinicians begin. Instead, they ask about confidence, co…
Company
VCAST
Artificial Intelligence based Virtual Coronary Stress Test
- Location
- Chicago, US
- Company size
- 2–10 employees
About VCAST
The Virtual Cardiac Stress Test (VCAST) is a patented, AI-based medical system developed for non-invasive, clinical quantitative and qualitative analysis of CT-scan data, to assess the hemodynamic significance of coronary artery atherosclerotic stenosis. The Kardiolytics cardiac test is rapid, inexpensive and entirely noninvasive. It provides personalized, color-coded, 3D modeling of the coronary arteries combined with detailed, functional diagnostic information regarding blood flow. This includes computed quantities of blood, pressure, and velocity and is designed to assist the physician both in completing the diagnosis and designing the treatment plan for coronary artery disease. The test provides information usually obtained only by the highly invasive FFR test (that involves inserting a pressure wire into coronary arteries). All data that are required for VCAST come from a widely available and inexpensive CT-scan imaging that is conducted by a technician and not a doctor and the results can be forwarded to a doctor remotely. It is independent of imaging equipment, imaging protocols, and equipment vendors.
See moreLatest activity
Latest activity from VCAST
2 signals
Discover more
Similar signals
Similar public activity from other companies.
Products & Services
Heartvue.AI
Heartvue.AI starts the Echo process by detecting what was actually acquired and recommending what needs to be reported, before the report is final.
Products & Services
Hoopcare
Hoopcare is building an AI model that reads routine ECGs and flags suspected left ventricular ejection fraction (LVEF) below 40% in seconds.
Products & Services
ACTAVA.ai
ACTAVA.ai develops the ACTAVA platform, which takes a healthcare workflow apart, decides where an agent acts and where a human gates the call, and runs it under governance.
Products & Services
Omega Medical Imaging LLC
Omega Medical Imaging LLC engineered Soteria AI with a patented telescoping SID and 5th-axis movement to support patient access and angulations during cardiovascular procedures.
Products & Services
Cleerly